Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Beijing, China
SEC filing record 1 source field available
Fiscal year end
31 December
CASI Pharmaceuticals, Inc. has filed 154 SEC EDGAR filings since 31 Jan 2023

SEC filing history

Showing 1-25 of 154 matching filings.

Per page
25
Current page
1
6-K File 001-41666

FORM 6-K

Filing date
15 Jul 2026
Reporting date
15 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41666

FORM 6-K

Filing date
29 Jun 2026
Reporting date
29 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-41666

25-NSE filing

Filing date
23 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41666

FORM 6-K

Filing date
02 Jun 2026
Reporting date
02 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-94039

SCHEDULE 13D/A filing

Filing date
18 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-582016

D filing

Filing date
28 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
23 Apr 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 20-F File 001-41666

NT 20-F

Filing date
21 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
20 Apr 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41666

FORM 6-K

Filing date
20 Apr 2026
Reporting date
20 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41666

FORM 6-K

Filing date
20 Apr 2026
Reporting date
20 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
16 Apr 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41666

FORM 6-K

Filing date
15 Apr 2026
Reporting date
15 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
13 Apr 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
07 Apr 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
03 Apr 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
03 Apr 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
27 Mar 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
25 Mar 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-94039

SCHEDULE 13D/A filing

Filing date
23 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
18 Mar 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
18 Mar 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41666

FORM 6-K

Filing date
03 Mar 2026
Reporting date
03 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-574723

D filing

Filing date
26 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .